全球动物模型市场

到 2030 年，全球动物模型市场规模将达到 37 亿美元

全球动物模型市场规模预计在2024年为24亿美元，到2030年将达到37亿美元，2024年至2030年的复合年增长率为7.4%。作为本报告分析的细分市场之一，小鼠市场预计将实现8.8%的复合年增长率，并在分析期结束时达到12亿美元。大鼠市场在分析期间内的复合年增长率预计为7.5%。

美国市场规模估计为 6.546 亿美元，中国市场预计复合年增长率为 11.8%

美国动物模型市场规模预计2024年达到6.546亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到7.883亿美元，在2024-2030年的分析期内，复合年增长率为11.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.7%和7.2%。在欧洲，预计德国市场的复合年增长率为4.9%。

全球动物模型市场－主要趋势与驱动因素摘要

为什么生物医学研究对动物模型的需求越来越大？

生物医学和製药研究中对动物模型的日益依赖是市场成长的主要驱动力。随着癌症、糖尿病和神经退化性疾病等慢性疾病的盛行率持续上升，对临床前研究的需求也日益增长，以评估新疗法的安全性和有效性。动物模型透过提供忠实模拟人类生理和病理的生物系统，在转化研究中发挥至关重要的作用，使研究人员能够深入了解疾病机制。对个人化医疗和基因治疗的日益关注进一步加速了对能够模拟特定人类遗传条件的基因改造动物模型的需求。此外，FDA 和 EMA 等监管机构要求在核准人体测试的药物之前使用动物模型进行临床前研究，这进一步增强了动物模型在药物开发平臺中的重要性。

科技进步如何影响动物模型市场？

基因工程和生物技术的创新正在彻底改变更精确、更可靠的动物研究模型的发展。 CRISPR-Cas9 基因编辑技术的开发使得创建高度特异性的基因改造动物模型成为可能，使研究人员能够研究特定基因在疾病发展和进展中的作用。人工智慧 (AI) 与数据分析在动物研究中的融合也透过自动追踪生理和行为反应提高了研究的精确度。此外，3D 生物列印和器官晶片技术的日益普及正在补充传统的动物模型，增强了进行更精确、更符合伦理道德的研究的能力。这些技术进步不仅提高了临床前研究的可重复性和可靠性，也为再生医学和毒性测试开闢了新的可能性。

动物模型市场面临哪些挑战与机会？

动物模型市场面临许多挑战，包括伦理问题、监管审查以及替代检测方法的可用性。围绕动物研究使用的伦理争议导致了更严格的指导方针出台，动物福利组织的压力也越来越大，促使该行业探索非动物替代品，例如试管内模型和电脑模拟。监管机构正在收紧动物福利合规要求，这进一步加剧了製药和研究机构的市场格局。然而，这些挑战也为市场相关人员提供了一个机会，可以开发更复杂、更人道的动物模型，最大限度地减少动物痛苦，同时最大限度地提高研究成果。人源化动物模型的应用日益广泛，这种模型结合了人类细胞和基因，可以更好地复製人类病理，也为肿瘤学、免疫学和感染疾病研究开闢了新的途径。

推动动物模型市场成长的关键因素有哪些？

动物模型市场的成长受到多种因素的推动，包括对新型疗法的需求不断增长、政府对生物医学研究的资助不断扩大、通用感染疾病的日益流行使得基于动物模型的研究成为必要。製药公司正在大力投资临床前研究以开发创新药物和生技药品，这推动了对能够提供可靠的功效和安全性数据的先进动物模型的需求。人们对疫苗开发的日益关注，特别是鑑于新出现的感染疾病和全球健康威胁，进一步推动了市场的发展。此外，在兽医研究中越来越多地使用动物模型来提高牲畜生产力和伴侣动物健康，这也促进了市场扩张。基因工程和分子生物学的不断进步正在推动动物模型市场的持续成长，为全球研究机构和行业相关人员提供了新的机会。

部分

动物类型（小鼠、大鼠、豚鼠、仓鼠、其他动物类型）；用途（癌症、感染疾病、免疫疾病、其他）；最终用途（製药/生物技术公司、受託研究机构、学术研究机构）

受访公司范例

• Biocytogen Boston Corp.
• Charles River Laboratories International, Inc.
• Crown Bioscience Inc.
• Cyagen US Inc.
• Genoway SA
• Hera Biolabs
• InnoSer Belgie NV
• Inotiv, Inc.
• Janvier Labs
• Ozgene Pty Ltd.
• Taconic Biosciences, Inc.
• The Jackson Laboratory

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Animal Model Market to Reach US$3.7 Billion by 2030

The global market for Animal Model estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Mice, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Rat segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$654.6 Million While China is Forecast to Grow at 11.8% CAGR

The Animal Model market in the U.S. is estimated at US$654.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$788.3 Million by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Animal Model Market - Key Trends & Drivers Summarized

Why Is the Demand for Animal Models Rising in Biomedical Research?

The growing reliance on animal models in biomedical and pharmaceutical research is a key driver of market growth. As the prevalence of chronic diseases such as cancer, diabetes, and neurodegenerative disorders continues to rise, there is an increasing need for preclinical studies to evaluate the safety and efficacy of new therapeutics. Animal models play a crucial role in translational research by providing a biological system that closely mimics human physiology and pathology, allowing researchers to gain critical insights into disease mechanisms. The expanding focus on personalized medicine and gene therapy has further accelerated demand for genetically modified animal models that can simulate specific human genetic conditions. Additionally, regulatory bodies such as the FDA and EMA mandate preclinical testing using animal models before approving drugs for human trials, further cementing their importance in the drug development pipeline.

How Are Technological Advancements Shaping the Animal Model Market?

Innovations in genetic engineering and biotechnology are revolutionizing the development of more precise and reliable animal models for research applications. Advances in CRISPR-Cas9 gene-editing technology have enabled the creation of genetically modified animal models with high specificity, allowing researchers to study the role of specific genes in disease development and progression. The integration of artificial intelligence (AI) and data analytics in animal research is also improving study accuracy by enabling the automated tracking of physiological and behavioral responses. Furthermore, the increasing adoption of 3D bioprinting and organ-on-chip technologies is complementing traditional animal models, enhancing the ability to conduct more accurate and ethically responsible research. These technological advancements are not only improving the reproducibility and reliability of preclinical studies but are also opening up new opportunities in regenerative medicine and toxicology testing.

What Challenges and Opportunities Exist in the Animal Model Market?

The animal model market faces several challenges, including ethical concerns, regulatory scrutiny, and the availability of alternative testing methods. Ethical debates surrounding the use of animals in research have led to stringent guidelines and increased pressure from animal rights organizations, prompting the industry to explore non-animal alternatives such as in vitro models and computer simulations. Regulatory agencies are imposing stricter compliance requirements related to animal welfare, further complicating the market landscape for pharmaceutical and research institutions. However, these challenges present opportunities for market players to develop more refined and humane animal models that minimize suffering while maximizing research outcomes. The increasing adoption of humanized animal models, which incorporate human cells or genes to better replicate human conditions, is also opening new avenues for research in oncology, immunology, and infectious diseases.

What Are the Key Factors Driving Growth in the Animal Model Market?

The growth in the Animal Model market is driven by several factors, including the rising demand for novel therapeutics, expanding government funding for biomedical research, and the increasing prevalence of zoonotic diseases that require animal model-based studies. Pharmaceutical companies are investing heavily in preclinical research to develop innovative drugs and biologics, fueling demand for sophisticated animal models that can provide reliable efficacy and safety data. The growing focus on vaccine development, particularly in light of emerging infectious diseases and global health threats, is further boosting the market. Additionally, the rising use of animal models in veterinary research to improve livestock productivity and companion animal health is contributing to market expansion. With continuous advancements in genetic engineering and molecular biology, the animal model market is poised for sustained growth, offering new opportunities for research institutions and industry stakeholders worldwide.

SCOPE OF STUDY:

The report analyzes the Animal Model market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Mice, Rat, Guinea Pig, Hamster, Other Animal Types); Application (Cancer Application, Infectious Disease Application, Immunological disease Application, Other Applications); End-Use (Pharma and Biotech Companies End-Use, Contract Research Organizations End-Use, Academic Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Biocytogen Boston Corp.
• Charles River Laboratories International, Inc.
• Crown Bioscience Inc.
• Cyagen US Inc.
• Genoway S.A.
• Hera Biolabs
• InnoSer Belgie NV
• Inotiv, Inc.
• Janvier Labs
• Ozgene Pty Ltd.
• Taconic Biosciences, Inc.
• The Jackson Laboratory

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Animal Model - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Preclinical Research in Drug Development Drives the Growth of Animal Model Usage
  • Technological Advancements in Genetic Engineering Enhance the Precision and Reliability of Animal Models
  • Increasing Regulatory Requirements for Drug Safety and Efficacy Strengthen the Business Case for Animal Models
  • Expansion of Biopharmaceutical and Biotechnology Industries Spurs Demand for Advanced Animal Model Testing
  • Growing Emphasis on Personalized Medicine Fuels Demand for Genetically Modified and Humanized Animal Models
  • Rising Prevalence of Chronic Diseases Encourages the Use of Animal Models in Biomedical Research
  • Ethical Concerns and Alternative Testing Methods Present Challenges and Opportunities for Market Innovation
  • Collaborations Between Academic Institutions and Pharmaceutical Companies Drive New Developments in Animal Model Research
  • Increasing Government and Private Funding for Life Sciences Research Boosts Market Growth for Animal Models
  • Emergence of Alternative 3D Culture Systems and In-Vitro Models Pose Competitive Challenges for Animal Testing
  • Expansion of Cancer Research and Oncology Studies Strengthens Demand for Rodent-Based Animal Models
  • Rising Use of Large Animal Models in Regenerative Medicine Research Enhances Market Potential
  • Technological Innovations in Imaging and Monitoring Systems Improve the Efficiency of Animal Model Studies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Animal Model Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Animal Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Animal Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Mice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Mice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Mice by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Rat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Rat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Rat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Guinea Pig by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Guinea Pig by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Guinea Pig by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hamster by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hamster by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hamster by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Infectious Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Immunological disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Immunological disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Immunological disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Animal Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Animal Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Animal Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Animal Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Animal Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION